Neuromuscular Unit, Neurology Department, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Department of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
J Peripher Nerv Syst. 2023 Sep;28(3):351-358. doi: 10.1111/jns.12581. Epub 2023 Jul 24.
Homozygous loss-of-function mutations in the RETREG1 gene result in Hereditary Sensory Autonomic Neuropathy Type 2B. Clinical features include pain loss, autonomic disturbances, and upper motor neuron features.
We evaluated the clinical and genetic features of seven patients from four families with RETREG1 variants.
Five patients were male. The median age of disease onset was 7.00 ± 2.81 (between 2 and 10 years). A combination of painless wounds, trophic changes, and foot ulcerations was the presenting symptom in five patients and walking difficulties in two. Motor symptoms were present in five patients. In a median disease duration of 30.00 ± 12.88 years, five patients had osteomyelitis, and three had toe amputations. A history of renal disease was present in one family. In another family, three affected siblings had short stature and a history of delayed puberty. Although sensory signs predominated the clinical findings, various degrees of motor signs such as muscle weakness, spasticity, and brisk tendon reflexes were noted in all patients. Nerve conduction studies showed axonal sensory-motor neuropathy in five patients and sensory neuropathy in two. Three pathogenic variants were identified in the RETREG1 gene. Two unrelated patients had a homozygous c.433C > T/p.(Gln145*), one a homozygous c.826delA/p.(Ser276Valfs8), and the last had a novel homozygous c.102delC/p.(Ala35Glnfs349) variants.
In our study, all patients showed signs and symptoms consistent with pain insensitivity. Although shadowed by sensory symptoms, motor signs were noted in our patients. Further studies are necessary to clarify the causal relationship between extra-neurological features and RETREG1 mutations.
RETREG1 基因的纯合功能丧失突变导致遗传性感觉自主神经病 2B 型。临床特征包括疼痛丧失、自主神经紊乱和上运动神经元特征。
我们评估了四个家族的 7 名 RETREG1 变异患者的临床和遗传特征。
5 名患者为男性。疾病发病的中位年龄为 7.00±2.81(2-10 岁之间)。5 名患者的首发症状为无痛性伤口、营养改变和足部溃疡,2 名患者为行走困难。5 名患者存在运动症状。在中位病程 30.00±12.88 年中,5 名患者发生骨髓炎,3 名患者行脚趾截肢。一个家族有肾病病史。另一个家族的 3 名受累同胞身材矮小,青春期延迟。尽管感觉体征主导了临床发现,但所有患者均存在不同程度的运动体征,如肌肉无力、痉挛和腱反射活跃。神经传导研究显示 5 名患者为感觉运动性轴索性神经病,2 名患者为感觉神经病。在 RETREG1 基因中发现了 3 个致病性变异。2 名无关联患者为纯合 c.433C>T/p.(Gln145*),1 名纯合 c.826delA/p.(Ser276Valfs8),最后 1 名为新的纯合 c.102delC/p.(Ala35Glnfs349)变异。
在我们的研究中,所有患者均表现出疼痛不敏感的体征和症状。尽管感觉症状较为突出,但我们的患者仍存在运动体征。需要进一步研究以阐明神经外特征与 RETREG1 突变之间的因果关系。